| Literature DB >> 31209039 |
Li Zhang1,2, Jingjing Meng2, Yuguang Ban3, Richa Jalodia2, Irina Chupikova2, Irina Fernandez4, Nivis Brito4, Umakant Sharma2, Maria T Abreu4, Sundaram Ramakrishnan2, Sabita Roy5.
Abstract
Prolonged exposure to opioids results in analgesic tolerance, drug overdose, and death. The mechanism underlying morphine analgesic tolerance still remains unresolved. We show that morphine analgesic tolerance was significantly attenuated in germfree (GF) and in pan-antibiotic-treated mice. Reconstitution of GF mice with naïve fecal microbiota reinstated morphine analgesic tolerance. We further demonstrated that tolerance was associated with microbial dysbiosis with selective depletion in Bifidobacteria and Lactobacillaeae. Probiotics, enriched with these bacterial communities, attenuated analgesic tolerance in morphine-treated mice. These results suggest that probiotic therapy during morphine administration may be a promising, safe, and inexpensive treatment to prolong morphine's efficacy and attenuate analgesic tolerance. We hypothesize a vicious cycle of chronic morphine tolerance: morphine-induced gut dysbiosis leads to gut barrier disruption and bacterial translocation, initiating local gut inflammation through TLR2/4 activation, resulting in the activation of proinflammatory cytokines, which drives morphine tolerance.Entities:
Keywords: germfree mice; gut dysbiosis; gut−immune−brain axis; morphine tolerance
Mesh:
Substances:
Year: 2019 PMID: 31209039 PMCID: PMC6613141 DOI: 10.1073/pnas.1901182116
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205